Bml Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $132 Billion
- Q2 2025
A detailed history of Bml Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 14,250,000 shares of ACRS stock, worth $23.4 Million. This represents 15.31% of its overall portfolio holdings.
Number of Shares
14,250,000
Previous 14,250,000
-0.0%
Holding current value
$23.4 Million
Previous $21.8 Billion
7.19%
% of portfolio
15.31%
Previous 17.65%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
120Shares Held
95.1MCall Options Held
35.4KPut Options Held
32K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.8 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14.6 Million3.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$10.9 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$8.28 Million0.46% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$7.65 Million0.15% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $109M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...